By Scott Gottlieb (original source The Wall Street Journal)
“Can America reopen without a major resurgence of Covid-19? We’ve learned a great deal about controlling the virus. In the summer people will spend time outdoors, which can reduce the risk. Yet a second wave could come in the fall as schools open and businesses try to return to normal. Americans will feel more confident—or simply tired—and may take fewer precautions.
Getting the threat behind us will require a vaccine cleared for general use. There are ways to accelerate that process, but it is important not to cut corners, lest the public lose confidence and refuse a vaccine. The urgent public-health need demands speed. But that doesn’t mean compromising robust data to prove safety and efficacy.
Almost a dozen vaccine candidates are in early clinical trials, with more on the way. Each of the six major drug makers with vaccine programs is developing a Covid-19 candidate. These efforts are moving at an unprecedented pace, thanks to innovative but often unproven vaccine-making technologies, many of which have never been used to make a licensed vaccine. These include gene-based vaccines that deliver parts of the coronavirus gene to the body.”
Click here to read more
Loretta Mester: Unhelpful to Have President Trump Trying to Pressure the Fed
Former Cleveland Fed President Loretta Mester joins ‘Squawk Box’ to discuss the mounting pressure on the Federal Reserve and Fed Chair Powell, state of the…
Thought Leader: Loretta Mester
Tony Abbott: Keeping the Right in the Fight
Sussan Ley is under no immediate threat as leader, but the party remains fundamentally divided and conflict lies just below the surface. Four days on…
Thought Leader: Tony Abbott
Dr. Sanjay Gupta: Should You “Lean Into” Your Chronic Pain to Relieve It?
Dr. Sanjay Gupta sits down with researcher and clinical therapist Dr. Eric Garland to explore how mindfulness meditation can be as effective as opioids in…
Thought Leader: Sanjay Gupta
